Related references
Note: Only part of the references are listed.Immunity in arterial hypertension: associations or causalities?
Hans-Joachim Anders et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)
Definitions of and contributions to cardiovascular disease in systemic lupus erythematosus
Johanna T. Gustafsson et al.
AUTOIMMUNITY (2014)
The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients
L. Eder et al.
LUPUS (2014)
Do current arterial hypertension treatment guidelines apply to systemic lupus erythematosus patients? A critical appraisal
Konstantinos Tselios et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2014)
Relation of Carotid Intima-Media Thickness and Plaque With Incident Cardiovascular Events in Women With Systemic Lupus Erythematosus
Amy H. Kao et al.
AMERICAN JOURNAL OF CARDIOLOGY (2013)
2013 ESH/ESC Guidelines for the management of arterial hypertension
Giuseppe Mancia et al.
EUROPEAN HEART JOURNAL (2013)
Incidence of and Risk Factors for Adverse Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Laurence S. Magder et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Premature Atherosclerosis Is Associated With Hypovitaminosis D and Angiotensin-Converting Enzyme Inhibitor Non-use in Lupus Patients
Roneka L. Ravenell et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2012)
Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
George K. Bertsias et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Use of atorvastatin in systemic lupus erythematosus in children and adolescents
L. E. Schanberg et al.
ARTHRITIS AND RHEUMATISM (2012)
Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers are beneficial in normotensive atherosclerotic patients: a collaborative meta-analysis of randomized trials
Finlay A. McAlister
EUROPEAN HEART JOURNAL (2012)
Renin-angiotensin-aldosterone system blockade for nephroprotection: current evidence and future directions
Leszek Tylicki et al.
JOURNAL OF NEPHROLOGY (2012)
Lupus Atherosclerosis Prevention Study (LAPS)
M. A. Petri et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Effects of Rosuvastatin on Vascular Biomarkers and Carotid Atherosclerosis in Lupus: A Randomized, Double-Blind, Placebo-Controlled Trial
Chi Chiu Mok et al.
ARTHRITIS CARE & RESEARCH (2011)
Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study
Wojciech Plazak et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Antiproteinuric Effect of Angiotensin-converting Enzyme Inhibitors and an Angiotensin H Receptor Blocker in Patients with Lupus Nephritis
N. Kitamura et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2009)
RAS meets SLE(*)
Rudolf P. Wuethrich
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Reno-prevention vs. reno-protection: a critical re-appraisal of the evidence-base from the large RAAS blockade trials after ontargeta call for more circumspection
M. A. C. Onuigbo
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Epidemiology of atherosclerosis in systemic lupus erythematosus
Mandana Nikpour et al.
Current Rheumatology Reports (2009)
Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus -: results from LUMINA (LIX):: a multiethnic US cohort
S. Duran-Barragan et al.
RHEUMATOLOGY (2008)
An ACE inhibitor reduces Th2 cytokines and TGF-β1 and TGF-β2 isoforms in murine lupus nephritis
DA De Albuquerque et al.
KIDNEY INTERNATIONAL (2004)
Angiotensin inhibition reduces glomerular damage and renal chemokine expression in MRL/lpr mice
GP De Lema et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Share Paper
